Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-129571

Options or other derivatives

  • Director acquired 26,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ross Michael Jay Director 2021-10-21 Grant or award · Stock Option (right to buy) +26,400 26,400 D: show line 1 in the form
Loading xslF345X03/tm2130646-22_4seq1.xml…